IOBT FY 2022 Earnings — IO Biotech, Inc. Revenue & Financial Results | Market Cap Arena

IOBTIO Biotech, Inc.

$21M

FY 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$540,000

Operating Income

-$71M

Net Income

-$71M

EPS (Diluted)

$-2.48

Cash Flow

Operating Cash Flow

-$60M

Free Cash Flow

-$60M

Stock-Based Comp.

$7M

Balance Sheet

Total Assets

$152M

Total Liabilities

$13M

Stockholders' Equity

$139M

Cash & Equivalents

$143M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$540,000	$0	—
Operating Income	-$71M	-$41M	-73.2%
Net Income	-$71M	-$68M	-5.3%